OBJECT TRACKING ALGORITHM BASED ON DUAL COLOR FEATURE FUSION WITH DIMENSION REDUCTION


Transition from parental prostacyclin to selexipag: a case series of five pulmonary arterial hypertension patients

Parental prostacyclin is the only therapy with a proven survival benefit in pulmonary arterial hypertension (PAH).However, some patients are unable to tolerate continuous prostacyclin infusion because of central line infection, side effects, or sociocultural factors.Selexipag is a recently approved prostacyclin receptor agonist that is able to blun

read more